FdaApplication

ANDA 209931

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2021-01-14

Products (1)

ProductActive ingredientStrengthDosage form
BEXAROTENEBEXAROTENE75MGCAPSULE;ORAL

1 product